Zibotentan, an EDN1A antagonist, prevents Aß-induced hypertension, maintains cerebral perfusion, and may have therapeutic potential for Alzheimer's disease (2019)
Attributed to:
MICA: ET-1-mediated reduction of cerebral blood flow in Alzheimer's disease: therapeutic potential of zibotentan
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Type: Journal Article/Review
Volume: 29 Suppl 1
Parent Publication: Brain Pathol